NCT02335671View on ClinicalTrials.gov

Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Early Stage Breast CancerBreast Cancer Stage IBreast Cancer Stage II
Interventions
PROCEDURE

Intra-operative Magnetic Resonance Imaging (MRI)

OTHER

Mass Spectrometer Analysis of Tissue Sample

Analysis of Tissue Sample

Trial Locations (2)

02215

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT02335671 - Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy | Biotech Hunter | Biotech Hunter